RANDAL J KIRK SC 13D 01-12-2011 ZIOPHARM

Company

Alaunos Therapeutics, Inc.

Filed

January 20, 2011

Accession Number

0001140361-11-003560

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →